Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorGüzel, Savaş
dc.contributor.authorYıldız, Özlem
dc.contributor.authorÜnal, Aysun
dc.contributor.authorKızıler, Ali Rıza
dc.contributor.authorGulyasar, Tevfik
dc.contributor.authorGüzel, Eda Çelik
dc.contributor.authorFidan, Çiğdem
dc.date.accessioned2022-05-11T14:12:34Z
dc.date.available2022-05-11T14:12:34Z
dc.date.issued2017
dc.identifier.issn2602-3032
dc.identifier.issn2602-3040
dc.identifier.urihttps://doi.org/10.17826/cutf.325707
dc.identifier.urihttps://hdl.handle.net/20.500.11776/5603
dc.description.abstractPurpose: Alzheimer disease (AD) is a progressive neurodegenerative disease that affects the neurons in various parts of the central nervous system. Recently discovered protein Doublecort like kinase-1 (DCLK-1) is one of the microtubule-associated protein. Our goal is to investigate the relationship of the role of the DCLK-1 in AD disease and oxidative stress. Material and Methods: The study included Alzheimerdisease- diagnosed 60 patients admitted to the clinic with memory disorders, and 30 healthy subjects. In the serum of patient and control group, DCLK-1, tau protein and zinc levels were measured. To assess the presence of oxidative stress, malondialdehyde (MDA), protein carbonyl group (PCG), protein thiol groups (PTG), glutathione (GSH) and catalase levels were detected. Dementia level was staged with Mini-Mental State Examination (MMSE) and Dementia Clinical Staging Scale (CDR). Results: Serum DCLK-1 and tau levels were determined significantly higher in AD compared to the control group). In the group with AD, levels of MDA, and PCG levels were significantly higher and GSH, catalase levels were determined significantly lower. DCLK-1 and MDA levels were determined significantly higher in the group with severe AD compared to the group with mild AD. In AD group, a positive correlation between DCLK-1 and, CDR and MDA; and negative correlation was found between MMSE and B12 vitamin Conclusions: The presence of a relation with increase in DCLK1 levels in AD and risk factors shows that it can be a new marker in assessing the disease.en_US
dc.language.isoturen_US
dc.publisherCukurova Univ, Fac Medicineen_US
dc.identifier.doi10.17826/cutf.325707
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectAlzheimer's diseaseen_US
dc.subjectDCLK-1en_US
dc.subjecttauen_US
dc.subjectzincen_US
dc.subjectoxidative stressen_US
dc.subjectMild Cognitive Impairmenten_US
dc.subjectOxidative Stressen_US
dc.subjectDamageen_US
dc.subjectProgressionen_US
dc.subjectProteinsen_US
dc.subjectZincen_US
dc.titleAlzheimer hastalığında doublecortin-like kinaz-1 düzeyleri ve oksidan durumuen_US
dc.title.alternativeDoublecortin-like kinase 1 levels and oxidant status in Alzheimer's diseaseen_US
dc.typearticleen_US
dc.relation.ispartofCukurova Medical Journalen_US
dc.departmentFakülteler, Tıp Fakültesi, Temel Tıp Bilimleri Bölümü, Tıbbi Biyokimya Ana Bilim Dalıen_US
dc.departmentFakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Aile Hekimliği Ana Bilim Dalıen_US
dc.authorid0000-0003-2520-6825
dc.identifier.volume42en_US
dc.identifier.issue4en_US
dc.identifier.startpage689en_US
dc.identifier.endpage695en_US
dc.institutionauthorGüzel, Savaş
dc.institutionauthorYıldız, Özlem
dc.institutionauthorGüzel, Eda Çelik
dc.institutionauthorFidan, Çiğdem
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.authorwosidFidan, Cigdem/X-7070-2018
dc.identifier.wosWOS:000414861000012en_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster